Focused on new business development and bringing client side perspective to current agency customer partnerships.

Leading the strategic execution of the Americas post acute DME and Disposable NPWT and Advanced Wound Dressings product portfolio business plans.

Leading the strategic execution of the US post acute DME and Disposable NPWT product portfolio business plans.

Led the US market launch and introduction of the CelluTome Epidermal Harvesting System after acquisition of the technology by KCI Inc.

Medical device startup focused on development and commercialization of a novel enabling technology that will facilitate the use of epidermal grafting in multiple dermatological and chronic wound procedures. Marketing consultant for the company prior to Series A funding. Second employee hired to lead market development, clinical studies, reimbursement assessment and initial sales efforts. Company acquired by Kinetic Concepts Inc.

Privately held marketing and sales medical device consulting organization.Demonstrated entrepreneurial success by launching and managing a medical device marketing and sales consulting organization.Projects included business and marketing plan development, new device opportunity appraisals, prototype clinical testing and evaluation, primary and secondary research data collection, interim product management roles, sales and marketing mentoring, corporate strategic planning, and new… Show more Privately held marketing and sales medical device consulting organization.Demonstrated entrepreneurial success by launching and managing a medical device marketing and sales consulting organization.Projects included business and marketing plan development, new device opportunity appraisals, prototype clinical testing and evaluation, primary and secondary research data collection, interim product management roles, sales and marketing mentoring, corporate strategic planning, and new business development activities. Client markets served included dermatological surgery, wound care, cardiology, gastrointestinal endoscopy, orthopedics, transplant surgery, dermatology, surgical endoscopy, hepatology, occupational medicine, bariatrics, pain management, anesthesia, and primary care. Show less

Consulting services from 2000-2004. Board of Advisors - At quarterly meetings, provided counsel to the Senior Management Team on the subjects of marketing and sales as part of a team of outside advisors.

Publicly held aesthetic laser device company. Managed six person corporate marketing department. Created proprietary 10,000+ aesthetic practice database to be used for device specific marketing campaigns and US field sales representative territory management. Resulted in significant reduction of cold calling.Identified new sources of sales leads. Hired and managed outside telemarketing resource. Resulted in 50% increase on monthly leads for domestic sales organization.Assumed… Show more Publicly held aesthetic laser device company. Managed six person corporate marketing department. Created proprietary 10,000+ aesthetic practice database to be used for device specific marketing campaigns and US field sales representative territory management. Resulted in significant reduction of cold calling.Identified new sources of sales leads. Hired and managed outside telemarketing resource. Resulted in 50% increase on monthly leads for domestic sales organization.Assumed interim product management responsibilities for pre-acquistion of new OEM laser product.Completed naming, product positioning, competitive analysis and pricing model. Show less

VC funded cardiology startup organization approaching first device commercialization. Hired and managed a Director of Sales and Marketing Communications ManagerCompany needed to secure new sources of financing. Collaborated with CEO, CFO and Needham & Company to develop road show tools. Made majority of marketing presentations to potential investors. Recognized need to secure unique billing code for company product as part of reimbursement process. Met with Medicare, and American… Show more VC funded cardiology startup organization approaching first device commercialization. Hired and managed a Director of Sales and Marketing Communications ManagerCompany needed to secure new sources of financing. Collaborated with CEO, CFO and Needham & Company to develop road show tools. Made majority of marketing presentations to potential investors. Recognized need to secure unique billing code for company product as part of reimbursement process. Met with Medicare, and American College of Cardiology advocacy group to solicit support. Secured first ICD-9 procedure code for intravascular chemography.Identified company need to develop relationships with KOLs. Recruited early adopter physicians to support device and market development process. Established early adopter physician working group whose members became both advisors and the company's first revenue generating customers. Show less

Publicly held diagnostic device cardiology organization. Responsible for managing the sales, marketing, clinical specialists and customer service departments. Exceeded sales forecast in Q1/06 by 15% and Q2/06 by 20% Device reimbursement was key hurdle to product adoption. Local Medicare policies poorly written. Engaged in year long process to secure National Medicare Coverage decision to reimburse for MTWA testing. Secured national reimbursement coverage and payment policies from… Show more Publicly held diagnostic device cardiology organization. Responsible for managing the sales, marketing, clinical specialists and customer service departments. Exceeded sales forecast in Q1/06 by 15% and Q2/06 by 20% Device reimbursement was key hurdle to product adoption. Local Medicare policies poorly written. Engaged in year long process to secure National Medicare Coverage decision to reimburse for MTWA testing. Secured national reimbursement coverage and payment policies from Medicare and private insurance carriersRecognized that later adopter physician wanted societal support. Worked with American College of Cardiology advocacy group and clinical guidelines department and secured Class II b clinical use guideline for MTWA test Show less

Subsidiary of WR Grace, publicly held company. First marketing and sales executive hired by the company. Parent company to dissociate from the medical products market and wind down Circe Biomedical in December 1999.Identified need for leadership role in moving company from Phase I to Phase II/III pitoval trial. Identified and screened major liver transplant hospitals in the US as potential clinical sites for next trial. Led and completed Phase III clinical site recruitment, budget and… Show more Subsidiary of WR Grace, publicly held company. First marketing and sales executive hired by the company. Parent company to dissociate from the medical products market and wind down Circe Biomedical in December 1999.Identified need for leadership role in moving company from Phase I to Phase II/III pitoval trial. Identified and screened major liver transplant hospitals in the US as potential clinical sites for next trial. Led and completed Phase III clinical site recruitment, budget and contract negotiations resulting in 50% savings of projected trial costsCreated commercialization plan for bioartificial liver system which was used to sell Circe Biomedical to a VC consortium Delivered external product development contract resulting in $100,000 in revenue Show less

Publicly held gastroenterology endoscope company. Managed direct domestic sales and European distributor organization, marketing and customer service departmentsRestructured sales organization from distributor network to direct sales team resulting in first year sales growth of 30%.Terminated existing ENT product distribution relationship and moved to alternative distribution channel resulting in 13% increase in product line gross profit margin Managed government lobbying… Show more Publicly held gastroenterology endoscope company. Managed direct domestic sales and European distributor organization, marketing and customer service departmentsRestructured sales organization from distributor network to direct sales team resulting in first year sales growth of 30%.Terminated existing ENT product distribution relationship and moved to alternative distribution channel resulting in 13% increase in product line gross profit margin Managed government lobbying efforts to secure Medicare reimbursement for disposable endoscope sheath, resulting in draft legislation (to mandate use of the sheath product) being included 1996 budget package Show less

Managed 3 product managers.Directed product groups that exceeded 1993 profit plan with over $80MM in salesCompleted marketing due diligence for specialty guide wire which was acquired in 1993Executed European product launch of next generation angioplasty catheter resulting in 10% share growth for balloon family of products

Managed 4 product managers. Authored and presented divisional 1993 Three Year Strategic Plan and Annual Profit Plan to corporate senior management team Grew division sales from $4MM in 1987 to $43 MM resulting in being named corporate division of the year for 1993

Increased endoscopic accessory device growth from 10% of total revenues in 1987 to 50% in 1992